You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Asian Handheld Devices The Asian Handheld Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “Asian Handheld Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into China, Japan, India, and Rest of Asia-Pacific (APAC). The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in handheld device market and extensively covered in this report. |
Upcoming |
|
|
European Internal Beam Radiotherapy/Brachytherapy Market The European Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $123.5 million in 2013 and expected to be $141.1 million by 2018, growing at a CAGR of 2.5%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Internal Beam Radiotherapy/Brachytherapy Market The Asian Internal Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $68.2 million in 2013 and expected to be $90.6 million by 2018, growing at a CAGR of 5.8%. The Internal Beam Radiotherapy Market analyzes the market of devices by 3 segments such as Brachytherapy Seeds, Applicators & Afterloaders and Electronic Brachytherapy.The prominent players in the Radiotherapy Devices Market globally areElekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Medical Automation Market The Asian Medical Automation Market was pegged at $6.6 billion in 2013 and expected to be $11.3 billion by 2018, growing at a CAGR of 11.3%. The report “Asian Medical Automation Market forecast, 2012-2018 “analyzes the market by 4 segments such as diagnostic and monitoring automation market, therapeutic automation market, lab and pharmacy automation market, and logistics and training automation market. The main companies operating in Medical automation market and extensively covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals and Konica Minolta Medical. |
Upcoming |
|
|
European Medical Automation Market The European Medical Automation market was $10.8 billion in 2013 and is expected to be $15.8 billion by 2018, at a CAGR of 7.8%. The report “European Medical Automation Market Forecast, 2012-2018”, analyzes the market by 4 segments such as diagnostic and monitoring, therapeutic, lab and pharmacy, and logistics and training. The key players of the market covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals, Konica Minolta Medical and others. |
Upcoming |
|
|
North American Medical Automation Market The North American Medical Automation market was $23.3 billion in 2013 and is expected to be $35.9 billion by 2018, at a CAGR of 9%. The diagnostic and monitoring automation market is the largest segment of North American medical automation market. The report “North American Medical Automation Market Forecast, 2012-2018”, analyzes the market by 4 segments such as diagnostic and monitoring, therapeutic, lab and pharmacy, and logistics and training. The key players of the market covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals, Konica Minolta Medical and others. |
Upcoming |
|
|
European Proteomics The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc. |
Upcoming |
|
|
European Non-Invasive Electrical Stimulators Market The report “The European Non-Invasive Electrical Stimulators Market devices market forecast 2012-2014” analyzes the market by technology into 2 segments such as Pulsed Electromagnetic Field Devices and Capacitive Coupling & Combined (electro) Magnetic Field Devices.Some of the key players in The European Non-Invasive Electrical Stimulators Market devices market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Automated External Defibrillators (AED) Asian market is expected to grow at the fastest rate.Recently North American Markets are showing a slow growth due to saturation of market.The Automated External Defibrillators Market can be segmented by Geographies, Product type, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in the report. |
Upcoming |
|
|
European Handheld Devices Market The European Handheld Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “European Handheld Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of the Europe. The report European Handheld Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Asian Insulin Delivery Devices The Asian Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “Asian insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into China, Japan, India, and Rest of the Asia-Pacific (APAC). The report Asian Insulin delivery Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North American Tissue Diagnostics The North American Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, value was estimated to be $1,228.14 million in 2013 and is expected to be $1,684.24 million by 2018, at a CAGR of 6.52% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.). |
Upcoming |
|
|
European Insulin Delivery Devices The European Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “European insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into U.K., Germany France, Italy, Spain, and Rest of the Europe. The report European Insulin delivery Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North American Insulin Delivery Devices The North American Insulin delivery Devices Market, mainly driven by increasing technological advancements, increasing prevalence to diabetes, increasing ageing population, increase in awareness of better diabetes management, and Product Innovation to increase acceptance. The report “North American insulin delivery Devices Market forecast, 2008-2018 “analyzes the market of devices by products such as; insulin pens, insulin syringes, insulin pumps. Geographically, the market is mainly segmented into U.S., Canada and Mexico. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North American Therapeutic Automation Market The North American Therapeutic Automation Market was valued at $7.4 billion in 2013 and is expected to reach $12.8 billion by 2018, at a CAGR of 11.7%. The report “North American Therapeutic Automation Market forecast, 2012-2018” analyzes the market by 2 segments such as surgical and non-surgical automation market. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others. |
Upcoming |
|
|
European Therapeutic Automation Market The European Therapeutic Automation Market was valued at $3.1 billion in 2013 and is expected to reach $4.8 billion by 2018, at a CAGR of 8.7%. The report “European Therapeutic Automation Market forecast, 2012-2018” analyzes the market by 2 segments such as surgical and non-surgical automation market. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others. |
Upcoming |
|
|
Asian Proteomics The Asian Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 1.42 billion in 2012 and is expected to be $ 4.16 billion by 2018, at a CAGR of 19.8%. The report “Asian Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Water Corporation, Roche, etc. |
Upcoming |
|
|
Asian Therapeutic Automation Market The Asian Therapeutic Automation Market was valued at $1.6 billion in 2013 and is expected to reach $2.9 billion by 2018, at a CAGR of 11.9%. The report “Asian Therapeutic Automation Market forecast, 2012-2018” analyzes the market by 2 segments such as surgical and non-surgical automation market. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others. |
Upcoming |
|
|
Asian Portable Diagnostic Imaging Devices Market The Asian Portable Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “Asian Portable Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 main segments such as by submarkets and by types. Geographically, the market is mainly segmented into China, Japan, India, and Rest of the Asia-Pacific (APAC) The report Asian Portable Devices Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North American Toxoid vaccines Market The North American Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $149.8 million in 2013 and expected to be $177.3million by 2018 at a CAGR of 3.4%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
Healthcare
